{"schema_version":"secwatch.filing_event.v1","accession":"0001641172-25-024614","form_type":"8-K","ticker":"BIAF","cik":"0001712762","company_name":"bioAffinity Technologies, Inc.","filed_at":"2025-08-18T23:59:59+00:00","discovered_at":"2026-05-14T18:02:44.752995+00:00","generated_at":"2026-05-17T11:57:45.335230+00:00","sec_items":["5.02","8.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"bioAffinity Technologies appoints Roberto Rios and John Oppenheimer to board; Gary Rubin resigns","bullets":["Roberto Rios (CPA) and John J. Oppenheimer (M.D.) appointed to Board, each term expiring at 2026 annual meeting.","Gary Rubin resigned from Board and Nominating Committee effective Aug. 12, 2025, not due to any disagreement.","Rios appointed Chair of Audit Committee and member of Compensation Committee; Oppenheimer on Nominating and Governance Committee.","Jamie Platt appointed to Audit Committee and as Chair of Nominating and Governance Committee; Robert Anderson on Compensation Committee.","New directors bring expertise in finance (Rios) and clinical respiratory research (Oppenheimer) to support CyPath Lung sales and pipeline."],"urls":{"canonical":"https://secwatch.observer/filing/0001641172-25-024614","json":"https://secwatch.observer/filing/0001641172-25-024614.json","markdown":"https://secwatch.observer/filing/0001641172-25-024614.md","text":"https://secwatch.observer/filing/0001641172-25-024614.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1712762/000164117225024614/0001641172-25-024614-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1712762/000164117225024614/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T11:57:45.335230+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}